SciHub
文献互助
期刊查询
一搜即达
科研导航
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
多多
Lv1
40 积分
2024-05-25 加入
最近求助
最近应助
互助留言
Randomized phase 2 dose comparison LITESPARK-013 study of belzutifan in patients with advanced clear cell renal cell carcinoma
22小时前
已完结
First Results of NURE-Combo: A Phase II Study of Neoadjuvant Nivolumab and Nab-Paclitaxel, Followed by Postsurgical Adjuvant Nivolumab, for Muscle-Invasive Bladder Cancer
22小时前
已完结
Treatment landscape of triple-negative breast cancer — expanded options, evolving needs
8天前
已完结
Efficiency and safety of neoadjuvant PD-1 inhibitor (sintilimab) combined with chemotherapy in potentially resectable stage IIIA/IIIB non-small cell lung cancer: Neo-Pre-IC, a single-arm phase 2 trial
9天前
已完结
IMpower150 Final Exploratory Analyses for Atezolizumab Plus Bevacizumab and Chemotherapy in Key NSCLC Patient Subgroups With EGFR Mutations or Metastases in the Liver or Brain
16天前
已完结
Impact of maintenance pemetrexed cessation on clinical outcomes of patients with metastatic non-squamous NSCLC
16天前
已完结
Neoadjuvant nivolumab plus chemotherapy versus chemotherapy for resectable NSCLC: subpopulation analysis of Chinese patients in CheckMate 816
24天前
已完结
Targeting SOST using a small-molecule compound retards breast cancer bone metastasis
24天前
已完结
Neoadjuvant nivolumab plus chemotherapy in resectable non‐small‐cell lung cancer in Japanese patients from CheckMate 816
24天前
已完结
Inhibition of PCSK9 potentiates immune checkpoint therapy for cancer
29天前
已完结
没有进行任何应助
感谢,速度真快,帮大忙了,么么哒
4个月前
感谢
4个月前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论